HomeVideos

Scientists Now Say This ONE Supplement Is "Non-Negotiable" After 65

Now Playing

Scientists Now Say This ONE Supplement Is "Non-Negotiable" After 65

Transcript

251 segments

0:00

Let's let's talk about the

0:00

multivitamins. So, this was the COSMOS

0:02

trial. I've talked a lot about the

0:03

COSMOS trial in the context of brain

0:06

aging. So, the larger there's, you know,

0:08

the larger trials and there was three

0:10

randomized controlled trials where these

0:13

older adults were given a standard

0:14

Centrum Silver multivitamin a day

0:17

every day and it was what is it about

0:19

3.6 years for this trial?

0:22

And

0:23

they were looking at I mean, there's a

0:25

lot of endpoints of this trial, but one

0:26

of them was cognitive function and brain

0:29

aging. And at the end of the trial, the

0:32

the people that were given the

0:33

multivitamin had slowed their brain

0:36

aging by 2.1 years. There's a battery of

0:39

tests that were done there and I'm not

0:40

sure if in fact some clocks were used as

0:42

well.

0:43

But I know that the global brain aging

0:45

was slowed by 2.1 years and their

0:47

episodic brain aging, so episodic memory

0:50

is the kind of memory where you're

0:52

remembering experiences, people, right?

0:54

Like those sorts of things. Um that was

0:56

slowed by almost 5 years compared to the

0:58

placebo group, which is quite

1:00

significant and they did better on a

1:01

battery of cognition tests.

1:04

And so that was very that's very

1:06

encouraging, you know, and it's

1:07

something that I do talk about a lot

1:08

because I feel like it's a very easy

1:11

safe intervention that people can take a

1:14

standard multivitamin. These have a

1:15

variety of

1:16

vitamins and minerals, trace elements

1:18

that people are not getting from their

1:20

diets. And so they're kind of filling

1:21

that nutritional gap. And

1:24

and so, you know, who doesn't want their

1:26

parents and grandparents to have better

1:27

brain aging? I think so. I'm my parents

1:29

are on a multivitamin, right?

1:31

Um when it comes to looking at these

1:34

epigenetic aging clocks,

1:37

the PhenoAge GrimAge clocks were the

1:39

ones that stood out to me. As you

1:40

mentioned, there was a battery of clocks

1:42

that were that were looked at, but it

1:44

seemed as though they were slowing or at

1:46

least

1:48

I I'm not exactly sure all the

1:49

calculations that go into this, but 2.7

1:52

months to 5 months, right? Like they

1:53

were basically

1:54

they're they're slowing the aging by

1:56

roughly that amount.

1:57

>> Yes.

1:58

>> Um

1:59

which to me is if you think about now

2:03

this this trial that was done

2:05

with the aging clocks, I think it was

2:07

like a subset of it of the larger trial.

2:09

Was it 2 years or did they do the 3.6

2:11

years for that? Do you

2:13

>> It was Yeah, I think it was 2 years.

2:15

>> 2 years, yeah. And and so um to me

2:19

the question is now this wasn't the you

2:21

said the duodenum paste didn't change.

2:23

>> No, it it it changed in the right

2:25

direction. It just wasn't statistically

2:28

significant.

2:29

>> Oh, I see. So

2:29

>> No, um

2:31

in the right direction, you know. Maybe

2:32

a larger sample size would have um led

2:35

to a significant finding. It was

2:37

definitely in the right direction.

2:38

>> Well, the question I have for you is if

2:40

you're changing it by, you know, 3 to 5

2:43

months within that 2-year range

2:45

according to the the GrimAge and

2:47

PhenoAge clocks

2:48

and you're to keep doing that, you know,

2:50

you know, for years. So now we're

2:51

talking not just 2 years, we're talking

2:54

20, we're talking 30, 40 years.

2:56

>> Yes.

2:57

>> How do you think that Do you think that

2:59

you get this accumulative effect?

3:02

>> Yes, I think so. I um I think so. I um

3:06

maybe to step back, if you tell an

3:09

80-year-old that um a multivitamin will

3:13

reduce his or her age by 3 months, they

3:16

will roll their eyes. They will say,

3:18

"Hey, give me something that reverses my

3:20

age by 30 years, you know."

3:22

Um

3:23

um so fair enough. The effect

3:26

it we just need to acknowledge the

3:27

effect is very minor, you know. However,

3:31

I like the way you conceptualize it. If

3:33

you

3:34

um really use it for 30 years, right?

3:37

You're a 50-year-old and you use it

3:40

until you're age 80,

3:42

my expectation is that suddenly these uh

3:45

3 months benefit they accumulate and

3:48

suddenly you have a benefit of maybe 2

3:50

and 1/2 years, you know? It's still not

3:55

great, you know, but there is a benefit,

3:58

you know, so um

3:59

>> But think of the effort you have to put

4:01

into just taking a multivitamin. Right?

4:04

I I think it's pretty great for that

4:06

amount of effort, you know, if you're if

4:08

you're just having to take one vitamin

4:10

supplement

4:11

>> Yes.

4:11

>> and it's going to delay your your brain

4:13

aging, you know, by 2.1 years just

4:16

after,

4:17

you know, in that trial it was 3.6 year

4:19

trial, but you know, that's pretty

4:20

robust. 5 years delaying brain episodic

4:23

brain aging.

4:24

>> Yes.

4:25

>> And and now we're talking about like

4:26

globally like

4:28

biological aging. If it's if it's

4:30

slowing it by, let's say, on the high

4:31

end 5 months after 2 years,

4:33

>> Yes.

4:34

>> I don't know. That seems like a pretty

4:36

great effect. If you're just taking a

4:37

vitamin supplement for 2 years it's

4:39

doing that, well, let's continue on and

4:41

and then combine them the things and

4:42

we'll get into some of the other trials

4:44

that do show synergy, but

4:45

>> Yes.

4:45

>> Um I think it's interesting. The other

4:47

question is that and this is where

4:50

um you know, the COSMOS trials, people

4:52

but they're looking at everything,

4:53

right? Cancer mortality, cardiovascular

4:55

mortality, all-cause mortality, and

4:58

those didn't really seem to change

5:00

>> Yes.

5:00

>> at least within the time frame

5:01

>> Yes.

5:02

>> that was looked at. And so,

5:04

you know, we see these epigenetic clocks

5:06

giving us a signal. We see the brain

5:07

aging effects and the question is why

5:10

are why are those showing up before

5:13

perhaps

5:13

>> I tell you my reading of it and um to me

5:17

this whole study was

5:19

one triumph for epigenetic clocks and I

5:21

explain to you why.

5:24

Assume you knew nothing um about

5:26

multivitamins. Um you would think that

5:30

there is a benefit, you know? Um clearly

5:33

vitamins are important. It's a trivial a

5:36

tautology.

5:37

>> Avoiding deficiencies are important.

5:39

>> especially, you know? So, you would say,

5:41

"Okay, I administer that to the US

5:44

population. I would hope [snorts] to see

5:47

an effect." and that of course is the

5:49

reason why these large-scale studies

5:51

were even initiated. Think about how

5:54

difficult it is to raise the funding for

5:56

such a large-scale study.

5:58

Clearly

5:59

there must be very compelling reasons.

6:02

Okay, but there's a problem now and

6:05

these hard endpoints, mortality,

6:08

cardiovascular disease, they didn't

6:10

detect an effect. It's deeply

6:12

frustrating.

6:14

>> Well, there was a trend, it wasn't

6:15

statistically significant.

6:18

>> Yeah, I I let you summarize it but to

6:20

me, you know, it um

6:22

I I I I just looked at it from the point

6:25

of view as a consumer. 5 years ago, you

6:27

know, I wouldn't take a multivitamin. I

6:29

looked at the literature, no benefit. I

6:31

won't take it, you know.

6:33

Now

6:34

um so um

6:37

a person can now make their own

6:38

judgment, you know, so what does it

6:40

mean?

6:41

To me, I take it as a wonderful triumph

6:45

of genetic clocks that they did pick up

6:48

the the signal.

6:50

And I um call this testing the test. You

6:54

have an intervention where um

6:57

you really think it's got to move the

7:01

needle, you know, and then if a readout

7:04

doesn't show it

7:06

one interpretation is well, maybe the

7:08

readout is too crude. Maybe

7:11

um all cause mortality is a real I mean,

7:14

we I like it as a readout. I used it for

7:16

GrimAge, don't get me wrong. I I like

7:18

that it's hard and definitive. You can't

7:21

argue with it. However, people die for a

7:25

hundred different reasons, you know,

7:27

that may really not relate to the uh

7:29

biology of aging, you know, and um so

7:32

now that we have actually biomarkers

7:35

that did pick up that signal even though

7:37

it's very weak is to me um

7:40

really reassuring, you know.

7:42

>> Yeah, and I think it's reassuring in

7:44

combination with the the the brain aging

7:47

signal that it picked up. And just

7:49

knowing that, you know, so many

7:52

globally people are not getting enough

7:55

of these important vitamins and minerals

7:57

and trace elements and essential fatty

7:58

acids from their diet, then it's kind of

8:01

like a an insurance. Like, okay, I'm

8:03

going to fill some of these nutritional

8:04

gaps. They won't all get filled because

8:06

you can't stuff everything into one

8:08

pill. I mean, you know,

8:10

you can only get a little bit of some

8:12

things in there, right?

8:13

>> Yes.

8:14

>> But I do think that it's it's again, I

8:16

agree with you. I think it is a triumph

8:18

and it's something that I do think that

8:21

is safe. I mean, it's really been shown

8:23

to be safe and so so maybe maybe you pee

8:27

a little bit more, but out. So what?

8:28

It's it's it seems to be doing something

8:30

beneficial for the brain and at least

8:33

for you know, looking at these aging

8:35

clocks, it seems like for the way your

8:36

aging as well.

8:37

>> Yes. Yeah, so what have you got to lose,

8:40

you know? Yeah.

Interactive Summary

This video discusses the findings from the COSMOS clinical trial regarding the effects of daily multivitamin supplementation on brain aging and biological aging clocks. The speakers highlight that although hard clinical endpoints like mortality and cardiovascular disease did not show statistically significant changes, the trial revealed notable improvements in cognitive function, specifically slowing global brain aging and episodic memory decline. Furthermore, they discuss how epigenetic clocks, such as PhenoAge and GrimAge, were able to detect subtle signals of slowed aging, which the speakers characterize as a triumph for these biomarkers and a justification for considering multivitamins as a safe, low-effort nutritional insurance policy.

Suggested questions

3 ready-made prompts